Sources

5 Total Sources

Aspen Wins Rights to Merck’s Monthly HIV Pill in 129 Countries

Left75%
Center25%
Bloomberg10h ago
Aspen Pharmacare Secures Rights for Once-Monthly HIV Prevention Pill in 129 Countries
The New York Times10h ago
Merck Licenses Generic Drugmakers for Low-Cost H.I.V. Prevention Pill Access
STAT21h ago
Merck Licenses Experimental HIV Prevention Pill Generics for 129 Countries
Reuters10h ago
Merck licenses experimental HIV pill to generic makers in 129 countries | Reuters
drugpatentwatch.com10h ago
Off-Patent Molecules, On-Patent Combinations: The DrugPatentWatch Playbook for Finding Formulation Gold - DrugPatentWatch – Transform Data into Market Domination